Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here's what happens next.

A group of independent advisers to the FDA is meeting Thursday and Friday to vote whether to reclassify seven peptides, which would broaden their availability in the U.S. A group of advisers to the ...

Most FDA advisers say the BPC-157 and KPV peptides should be made available in the US Here’s what happens next

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to ...